<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
><channel><title>Коментари на: Obaveštenje o povlačenju serija lekova sa aktivnom supstancom ranitidin, proizvođača Union Quimico Farmaceutica, S.A. (Uquifa S.A.) – Spain</title><atom:link href="/obavestenje-o-povlacenju-serija-lekova-sa-aktivnom-supstancom-ranitidin-proizvodjaca-union-quimico-farmaceutica-s-a-uquifa-s-a-spain/feed/" rel="self" type="application/rss+xml" /><link>/obavestenje-o-povlacenju-serija-lekova-sa-aktivnom-supstancom-ranitidin-proizvodjaca-union-quimico-farmaceutica-s-a-uquifa-s-a-spain/</link><description>Za stručnu medicinsku javnost</description><lastBuildDate>Tue, 25 Aug 2020 20:53:28 +0000</lastBuildDate><sy:updatePeriod>hourly</sy:updatePeriod><sy:updateFrequency>1</sy:updateFrequency><generator>https://wordpress.org/?v=7.0.1</generator><item><title>Од: Анонимни</title><link>/obavestenje-o-povlacenju-serija-lekova-sa-aktivnom-supstancom-ranitidin-proizvodjaca-union-quimico-farmaceutica-s-a-uquifa-s-a-spain/#comment-91</link><dc:creator><![CDATA[Анонимни]]></dc:creator><pubDate>Tue, 25 Aug 2020 20:53:28 +0000</pubDate><guid isPermaLink="false">/?p=81771#comment-91</guid><description><![CDATA[5]]></description><content:encoded><![CDATA[<p>5</p>]]></content:encoded></item></channel></rss>